COMMUNIQUÉS West-GlobeNewswire

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
13/08/2026
Planning to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene) in localized, intermediate- to high-risk prostate cancer in Q4 2026 Pivotal phase 3 clinical data published in The [...]
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
13/08/2026
Cash and Cash Equivalents of $28.4 Million as of June 30, 2026 Providing Runway Through Mid-2027; Company Advances Chemistry, Manufacturing and Controls (CMC) Work Toward NDA Resubmission KANSAS CITY, Kan., Aug. 13, [...]
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
13/08/2026
First-ever oral direct KCC2 activator, OV4071, advancing in an ongoing Phase 1 study Initiated Phase 2 proof-of-concept and photosensitivity studies for OV329, a next-generation GABA-AT inhibitor A newly-formed [...]
Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
13/08/2026
First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day [...]
PDS Biotech Reports Second Quarter 2026 Financial Results
13/08/2026
PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for [...]
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
13/08/2026
- Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026, 217 patients enrolled – - Commencement of Phase 2b Long-Term Extension Study to assess Halneuron ® reduction in [...]
SS Innovations Reports Second Quarter 2026 Financial Results
13/08/2026
Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales FORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS [...]
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
13/08/2026
WOBURN, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Opción Yo Earns a Place Among the Top 3% of the Inc. 5000
13/08/2026
MIAMI, FL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- — This recognition reflects a profound cultural shift as more people prioritize emotional well-being with the same intention they have long invested in their physical well- [...]
CurePSP Establishes Public Policy and Advocacy Team to Accelerate National Impact
13/08/2026
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- CurePSP has formally established its Public Policy and Advocacy team with the recent additions of Nora Wong, MPH, Associate Director of Public Policy, and Julie Balasalle, MSW [...]
MapLight Therapeutics Announces $150 Million Private Placement Financing
13/08/2026
SAN FRANCISCO and BOSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating [...]
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
13/08/2026
Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside MIAMI, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK [...]
Meet Pomoni: Physician-Founded Polyphenol Brand Unveils New Name, New Olive Oil Supplement for Athletes
13/08/2026
Pomoni debuts Phenolia Endurance,Sponsors Iowa City's core4 Gravel Earth Series race BETTENDORF, Iowa, Aug. 13, 2026 (GLOBE NEWSWIRE) -- O-Liv , the physician-founded brand behind HPLC-verified Greek olive polyphenols, [...]
Acentra Health Awarded Five-Year Contract Extension to Continue Utilization Management Services in Colorado
13/08/2026
Contract allows state to promote quality and cost-effective healthcare for 1.3 million Coloradans MCLEAN, Va., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company dedicated to [...]
New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema Treatment
13/08/2026
The FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment decisions. San [...]
Arisan Therapeutics Selected for NIAID Contract Award to Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection
13/08/2026
Contract Valued at Up to $24 million Supports IND-Enabling Studies for Arisan’s Lead Candidate with Demonstrated Activity Against Multiple Ebolaviruses CARLSBAD, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Arisan [...]
Early-Bird Deadline Approaches for 2nd Annual Guardian Initiative Charity Golf Tournament as Veterans Seek Sponsors to Play
13/08/2026
Players have until August 28 to take advantage of early-bird pricing for the September 28 charity tournament at Maderas Golf Club, while local veterans are seeking sponsors for the opportunity to participate. San Diego [...]
Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
13/08/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026. Later on the same day, the company will host a presentation for investors [...]
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
13/08/2026
SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk [...]

Pages